Bob Delise is founder and President of Artisan Healthcare Consulting. He has provided strategic and tactical brand advice for healthcare product companies since the early 1990s. Bob founded Artisan on the basis of outstanding client service – a belief he feels makes the difference between a good consulting company and an exceptional one.
During his career, Bob has provided strategic and tactical advice to more than 100 biotechnology, pharmaceutical, device and diagnostic brands worldwide. He has deep roots in biotechnology and specialty markets, and he has worked with leading products in oncology, hematology, autoimmune diseases, CNS, anti-infectives, hospital products, and ultra-orphan diseases.
Bob also advises clients on new product development, licensing opportunities, and deal valuation. Bob has examined hundreds of licensing opportunities for clients ranging from top 5 pharmaceutical companies to venture-backed emerging organizations.
Bob graduated Magna Cum Laude from Dartmouth in 1992.
Eric has over 20 years of pharmaceutical and biotech experience, providing strategic and tactical advice to over 100 brands across multiple therapeutic areas, including autoimmune diseases, cardiovascular, diabetes, CNS, and oncology.
Areas of expertise include:
- Commercial strategy development for launch and life cycle brands
- Commercial data analytics, including data evaluation, data integration, claims analysis, and management reporting
- Extensive U.S. Market Access activities, such as payer strategy, pricing and contracting, health plan segmentation and targeting, and support for various tactical programs
- End-to-End Voice-of-Customer research designed to identify unmet needs of the customer while delivering innovative solutions and differentiation throughout the brand lifecycle
- Global pharmaceutical supply chain strategy, product and market prioritization, life cycle management
Prior to joining Artisan, Eric served in multiple leadership roles with companies in the biopharmaceutical industry including G.D. Searle, Biogen, and HealthLeaders-InterStudy.
Eric completed his undergraduate studies at Fordham University and holds and MBA from the FW Olin Graduate School of Business at Babson College.
Brad Payne is Partner for Artisan Healthcare Consulting. He has led and delivered >100 consulting engagements across multiple therapeutic areas, including oncology, rare diseases, cardiovascular, and medical devices.
Areas of expertise include:
Early commercial strategy development for biopharma and medical devices
Broad L&A support, from BD strategy to short-term due diligence assessments
Market access strategy development for pipeline and late-stage products
Professional achievements include:
- Development and leadership of multiple consulting teams
- Lead advisor for 15+ device and pharmaceutical product launches
Prior to joining Artisan, Brad was a consultant at Trinity Partners, where he provided insight on forecasting projects, licensing and acquisition opportunities, and provided recommendations for managed care contracting strategies.
Brad graduated with a degree in economics Cum Laude from Harvard University and received an MBA from the W.P. Carey School of Business at Arizona State University.
Brad was a featured presenter at the recent New Product Planning Summit. Click here to download his presentation, Making the Target Product Profile a Tool and Not a Task to be Completed.
Brad Ship is Vice President at Artisan Healthcare Consulting with over 10 years of management consulting experience. He specializes in providing strategic analysis and guidance to life-science clients. Brad combines backgrounds in both management and the technical sciences to drive answers to the industry’s complex business challenges. Brad has worked with clients of all sizes, from top-20 pharmaceutical companies to early-stage emerging biotechs. He understands that the demands and focus of each company are different, and require unique perspectives.
Brad has experience across many therapeutic areas, including oncology, rare disease, and other speciality markets. He is one of Artisan’s leading experts in rare diseases, and gene and cell therapies.
Brad has a B.S. in Engineering from Lafayette College and a Master’s in Engineering Management from Dartmouth College.
Greg Wolfe is a Partner at Artisan Healthcare Consulting. He has over ten years of experience providing consulting services to leading biopharmaceutical and medical device companies. His interests include quantitative analysis of large data sets, forecasting, stochastic methods including Monte Carlo analysis, and complex epidemiology.
Greg has deep experience in a diverse range of therapeutic areas, having led numerous projects in oncology, immunology, neurology, cardiometabolic disease, infectious disease, pain, and rare diseases.
Prior to joining Artisan, Greg was a consultant at Equinox Group, where he built commercial forecasts, conducted primary research with key opinion leaders, and analyzed claims data sets to support new product and brand teams at pharmaceutical and device clients. At Equinox Group, he developed innovative simulation techniques to model patient dynamics in complex oncology and immunology markets.
Greg graduated with a B.A. in Physics cum laude from Harvard University.